# Evaluating Perioperative Outcomes: Dexmedetomidine vs Lignocaine in Laparoscopic Chlolecystectomy

> **NCT06740903** · PHASE2,PHASE3 · RECRUITING · sponsor: **Sahiwal medical college sahiwal** · enrollment: 140 (estimated)

## Conditions studied

- Hemodynamics Instability
- Post Operative Pain
- Gastrointestinal Dysfunction
- Cholecystitis

## Interventions

- **DRUG:** inj. dexmedetomidine infusion @ 0.2-0.4 μg/kg/h
- **DRUG:** inj. lignocaine infusion @1-2 mg/kg/h

## Key facts

- **NCT ID:** NCT06740903
- **Lead sponsor:** Sahiwal medical college sahiwal
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-06
- **Primary completion:** 2025-08-06
- **Final completion:** 2025-09-06
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2024-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06740903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06740903, "Evaluating Perioperative Outcomes: Dexmedetomidine vs Lignocaine in Laparoscopic Chlolecystectomy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06740903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*